Cargando…
Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity
BACKGROUND/AIMS: Growth differentiation factor 15 (GDF-15) belongs to the transforming growth factor-β superfamily. GDF-15 is emerging as a biomarker for several diseases. The aim of this study was to determine the clinical performances of GDF-15 for the prediction of liver fibrosis and severity in...
Autores principales: | Lee, Eaum Seok, Kim, Seok Hyun, Kim, Hyun Jin, Kim, Kyung Hee, Lee, Byung Seok, Ku, Bon Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347653/ https://www.ncbi.nlm.nih.gov/pubmed/27728964 http://dx.doi.org/10.5009/gnl16049 |
Ejemplares similares
-
Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
por: Choung, Sorim, et al.
Publicado: (2019) -
Validation and modification of existing mortality prediction models for lower gastrointestinal bleeding: a retrospective study
por: Lee, Hyun Seok, et al.
Publicado: (2021) -
Serum procalcitonin levels can be used to differentiate between inflammatory and non-inflammatory diarrhea in acute infectious diarrhea
por: Shin, Hae Jin, et al.
Publicado: (2018) -
A Case of Liver Fibrosis with Splenomegaly after Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer
por: Kang, Gu Hyum, et al.
Publicado: (2013) -
Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report
por: Park, Dae Hwa, et al.
Publicado: (2017)